Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc). Sub-analysis of the results in Argentina

Authors

  • Daniel Piskorz Instituto de Cardiología del Sanatorio Británico, Rosario, Santa Fe, Argentina
  • Ricardo López Santi Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina
  • Fernando Wyss Quintana Cardiovascular Services and Technology of Guatemala – CARDIOSOLUTIONS, Guatemala
  • Mildren Del Sueldo Clínica de Especialidades Villa María, Córdoba, Argentina
  • Sofía Brondello Clínica de Especialidades Villa María, Córdoba, Argentina
  • Gonzalo Piskorz Data IQ, Buenos Aires, Argentina
  • Mauro Ruise Departamento Docencia, Facultad de Ciencias Médicas, Universidad Nacional de Santiago Del Estero, Santiago del Estero, Argentina
  • Eva Fernández Instituto de Cardiología de Corrientes "Juana Francisca Cabral", Corrientes, Argentina
  • Diego Stisman Ginza Centro Médico, Yerba Buena, Tucumán, Argentina
  • Albertina Ghelfi Unidad de Hipertensión Arterial y Riesgo Cardiovascular, Hospital Escuela Eva Perón, Granadero Baigorria, Santa Fe, Argentina
  • Gonzalo Pérez Clinica Olivos, Buenos Aires, Argentina
  • Sergio Giménez OSEP Obra Social de Empleados Públicos, Mendoza, Argentina

DOI:

https://doi.org/10.63600/n3rfh314

Keywords:

Vaccines, Registry, Influenza, Pneumococcus pneumoniae, Covid-19, Argentina, Barriers

Abstract

In Argentina, the influenza and pneumococcal disease mortality rate has increased in recent years. Objective: the objective of this sub-analysis of the Inter-American Registry of Influenza and Pneumococcal Disease Vaccination (CorVacc) is to determine vaccination rates and analyze the factors that influence them in Argentina. Materials and methods: A cross-sectional survey of the general population was conducted in 19 Latin American countries. Adults over 18 years of age completed a 34-question online survey. The data were grouped into seven categories: demographic, socioeconomic, and vaccination profile. Results: 2,128 responses out of 21,389 were obtained from Argentina; 61% (n = 1,349) of the participants were female, and the mean age was 46.59 ± 15.88 years; 58.23% of the sample received annual influenza vaccination, 49.67% received the pneumococcal disease vaccine, and 88.33% received at least three doses of the COVID-19 vaccine. Low educational attainment and poor confidence on vaccines were the main barriers to vaccination. Older individuals and healthcare professionals received vaccines more frequently. Conclusions: the vaccination rate in Argentina is lower than that recommended by ministerial authorities and medical practice guidelines. The Inter-American Registry of Influenza and Pneumococcal Disease Vaccination (CorVacc) identified some of the implementation barriers. Public health authorities and health funders will be able to use this information to design their action plans.

References

1 Organización Panamericana de la Salud. Indicadores básicos Argentina 2024. Disponible en https://iris.paho.org/items/13655c32-515a-4b95-bc91-6298f5dfbd3b Acceso 12 de Diciembre de 2025.

2 Ministerio de Salud. Calendario Nacional de Vacunación. Vacuna Antigripal. Disponible en https://www.argentina.gob.ar/salud/vacunas/antigripal Acceso 7 de Diciembre de 2025.

3 Ministerio de Salud. Calendario Nacional de Vacunación. Vacuna contra el Neumococo. Disponible en https://www.argentina.gob.ar/salud/vacunas/neumococo Acceso 7 de Noviembre de 2025.

4 Ministerio de Salud. Manual de Vacunación. 20 de Agosto de 2024. Disponible en https://www.argentina.gob.ar/sites/default/files/2021/01/lineamiento_tecnico_pfizer_monovariante_692024.pdf Acceso 7 de Diciembre de 2025.

5 Santi RL, Márquez MF, Piskorz D, et al. Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study. Glob Heart 2021; 16: 15.

6 Sosa Liprandi Á, Zaidel EJ, Lopez Santi R, et al. Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study. Vaccines (Basel) 2021; 9: 123.

7 Wyss F, Lopez-Santi R, Piskorz D, et al, On Behalf of The CorVacc Study investigators. Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results. Global Heart 2025; 20: 108.

8 Piskorz D, Wyss Quintana F, López Santi R, et al. Latin American physicians’ perception toward vaccination. A CorVACC-AMERICA study sub-analysis. Latin American physicians’ perception toward vaccination. A CorVACC-AMERICA study sub-analysis. Arch Cardiol Mex; en prensa.

9 Wyss F, Lopez-Santi R, Piskorz D, et al. Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design. Arch Cardiol Mex 2025; 95: 144 - 152.

10 Ministerio de Salud. Calendario Nacional de Vacunación. Vacuna antigripal anual. Disponible en https://www.argentina.gob.ar/salud/vacunas/novedadantigripal Acceso 12 de Noviembre de 2025.

11 Ministerio de Salud. Calendario Nacional de Vacunación. Disponible en https://www.argentina.gob.ar/sites/default/files/2025-01-v2-calendario-nacional-vacunacion.pdf Acceso 12 de Noviembre de 2025.

12 García-Zamora S, Pulido L, Sosa-Liprandi MI, et al. Documento de Consenso sobre el rol de la vacunación en adultos para la prevención de eventos cardiovasculares. Posicionamiento conjunto de la Federación Argentina de Cardiología (FAC), Sociedad Argentina de Cardiología (SAC) y el Consejo Argentino de Residentes de Cardiología (CONAREC). Rev Fed Arg Cardiol 2025; 54 (Suplemento 7): 3 - 23.

13 Liprandi ÁS, Liprandi MIS, Zaidel EJ, et al. Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart 2021; 16: 55.

14 Fraze Jami L, Asif Amimah F, Zajac J. Case Studies of Rapid Community Assessment Implementation to Improve Vaccine Confidence and Demand During the COVID-19 Vaccine Rollout. Journal of Public Health Management & Practice 2025; DOI: 10.1097/PHH.0000000000002308.

Downloads

Published

2026-03-30

How to Cite

1.
Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc). Sub-analysis of the results in Argentina. Rev. Fed. Arg. Cardiol. [Internet]. 2026 Mar. 30 [cited 2026 Sep. 26];55(1):40-4. Available from: https://revistafac.org.ar/ojs/index.php/revistafac/article/view/776